Literature DB >> 27791949

Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome.

Antonio Vitale1, Ida Orlando1, Giuseppe Lopalco2, Giacomo Emmi3, Marco Cattalini4, Bruno Frediani1, Mauro Galeazzi1, Florenzo Iannone2, Donato Rigante5, Luca Cantarini6.   

Abstract

OBJECTIVES: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome is a non-Mendelian autoinflammatory disorder until now considered to be specifically limited to paediatric age. Recently, an increasing number of reports seems to suggest that PFAPA syndrome, diagnosed by the Marshall criteria revised by Thomas et al., can also affect adults.
METHODS: The Marshall/Thomas criteria have been applied to 989 adult patients presenting for recurrent fever episodes: all patients enrolled were reviewed for demographic, clinical, and therapeutic data. Infectious, neoplastic, autoimmune and other autoinflammatory diseases were ruled out.
RESULTS: We identified 30 adult patients (19 males, 11 females) with a suspected PFAPA syndrome: their mean age at disease onset was 33.75±14.01 years, mean age at diagnosis 39.1±14.39 years, and mean body temperature peak 39.5±0.7°C. In addition, the mean frequency of febrile episodes was 11.58±8.97 per year. More precisely, patients complained of pharyngitis (77%), cervical adenitis (73%), asthenia (63%), arthralgia (67%), oral aphthosis (50%), myalgia (54%), cephalalgia (43%), abdominal pain (27%), nausea/vomiting (17%), periorbital pain (17%), and arthritis (10%). Six out of 30 (20%) patients had suffered from PFAPA syndrome also during childhood, and the disease had reappeared in adulthood.
CONCLUSIONS: We provide the largest monocentric cohort of patients diagnosed with a suspected PFAPA syndrome in adulthood confirming that this syndrome can occur also during adulthood; moreover, due to the medical history of our patients and based on our experience, PFAPA syndrome might relapse during adulthood after a temporary remission reached in the course of paediatric age.

Entities:  

Mesh:

Year:  2016        PMID: 27791949

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  10 in total

Review 1.  Ulcerated Lesions of the Oral Mucosa: Clinical and Histologic Review.

Authors:  Sarah G Fitzpatrick; Donald M Cohen; Ashley N Clark
Journal:  Head Neck Pathol       Date:  2019-03-07

Review 2.  Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences.

Authors:  Amra Adrovic; Sezgin Sahin; Kenan Barut; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2018-07-17       Impact factor: 2.631

3.  Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome: A Rare Etiology of Fever in Adults.

Authors:  Sérgio Ferreira Cristina; Adriana Costa; Manuel Toscano; Estela Kakoo Brioso; Patrícia Cipriano
Journal:  Cureus       Date:  2021-04-29

4.  An Underlooked Cause of Periodic Fever (PFAPA) in an Adult Patient with No Response to Tonsillectomy.

Authors:  Fiaz Alam; Mohammed Hammoudeh
Journal:  Case Rep Rheumatol       Date:  2018-05-02

5.  Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome persisting to adulthood - an example of a diagnostic and therapeutic challenge.

Authors:  Ewa Więsik-Szewczyk; Beata Wolska-Kuśnierz; Karina Jahnz-Różyk
Journal:  Reumatologia       Date:  2019-10-31

Review 6.  Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases.

Authors:  Carla Gaggiano; Donato Rigante; Antonio Vitale; Orso Maria Lucherini; Alessandra Fabbiani; Giovanna Capozio; Chiara Marzo; Viviana Gelardi; Salvatore Grosso; Bruno Frediani; Alessandra Renieri; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2019-12-31       Impact factor: 4.711

7.  Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome.

Authors:  Francesca Della Casa; Antonio Vitale; Marco Cattalini; Francesco La Torre; Giovanna Capozio; Emanuela Del Giudice; Maria Cristina Maggio; Giovanni Conti; Maria Alessio; Benson Ogunjimi; Gaafar Ragab; Giacomo Emmi; Emma Aragona; Teresa Giani; Giuseppe Lopalco; Paola Parronchi; Farhad Shahram; Elena Verrecchia; Francesca Ricci; Fabio Cardinale; Silvia Di Noi; Rossana Nuzzolese; Riccardo Lubrano; Serena Patroniti; Roberta Naddei; Vito Sabato; Mohamed A Hussein; Laura Dotta; Violetta Mastrorilli; Stefano Gentileschi; Abdurrahman Tufan; Valeria Caggiano; Mohamed Tharwat Hegazy; Jurgen Sota; Ibrahim A Almaghlouth; Amr Ibrahim; Ewa Wiȩsik-Szewczyk; Burcugul Ozkiziltas; Salvatore Grosso; Micol Frassi; Maria Tarsia; Rosa Maria R Pereira; Maged Taymour; Carla Gaggiano; Sergio Colella; Claudia Fabiani; Maria Morrone; Piero Ruscitti; Bruno Frediani; Veronica Spedicato; Henrique A Mayrink Giardini; Alberto Balistreri; Donato Rigante; Luca Cantarini
Journal:  Front Pediatr       Date:  2022-07-22       Impact factor: 3.569

8.  Colchicine versus cimetidine: the better choice for Periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome prophylaxis, and the role of MEFV gene mutations.

Authors:  Payman Sadeghi; Mahdieh Vahedi; Seyed Reza Raeeskarami; Kosar Asna Ashari; Mahdieh Mousavi T; Vahid Ziaee
Journal:  Pediatr Rheumatol Online J       Date:  2022-08-31       Impact factor: 3.413

9.  Epidemiology and clinical features of PFAPA: a retrospective cohort study of 336 patients in western Sweden.

Authors:  Karin Rydenman; Hanna Fjeld; Josefine Hätting; Stefan Berg; Anders Fasth; Per Wekell
Journal:  Pediatr Rheumatol Online J       Date:  2022-09-15       Impact factor: 3.413

10.  Diagnostic Criteria for Adult-Onset Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome.

Authors:  Luca Cantarini; Antonio Vitale; Ludovico Luca Sicignano; Giacomo Emmi; Elena Verrecchia; Isabella Patisso; Lucia Cerrito; Claudia Fabiani; Gabriele Cevenini; Bruno Frediani; Mauro Galeazzi; Donato Rigante; Raffaele Manna
Journal:  Front Immunol       Date:  2017-08-24       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.